Heinemann, V.; Ebert, M. P.; Laubender, Rüdiger P.; Bevan, P.; Mala, C. and Boeck, S.
(2013):
Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancer.
In: British Journal of Cancer BJC, Vol. 108, No. 4: pp. 766-770
DOI: 10.1038/bjc.2013.62
| Item Type: | Journal article |
|---|---|
| Faculties: | Medicine > Institute for Medical Information Processing, Biometry and Epidemiology |
| Subjects: | 600 Technology > 610 Medicine and health |
| ISSN: | 0007-0920 |
| Language: | English |
| Item ID: | 33246 |
| Date Deposited: | 15. Feb 2017, 14:43 |
| Last Modified: | 04. Nov 2020, 13:10 |
Actions (login required)
- View Item
